Medicines Patent Pool Welcomes WHO’s Updated Essential Medicines List
WHO Calls On Originators To License Their Medicines To MPP
Executive Summary
The World Health Organization’s updated essential medicines list includes four medicines already licensed to the Medicines Patent Pool, of which two were developed through MPP licensees. The WHO’s updated list includes SGLT2 inhibitors – oral medications used to lower blood glucose levels – for which the MPP and the International Diabetes Federation have committed to improve affordable access in low- and middle-income countries.